Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study

Metabolism: Clinical and Experimental

Volumn 56, Issue 3, 2007, Pages 348-356

  Onat, Altan ^a,b   Sari, Ibrahim ^d   Hergenç, Gülay ^e   Yazici, Mehmet ^f   Uyarel, Hüseyin ^d   Can, Günay ^b   Sansoy, Vedat ^c  

^a Turkish Society of Cardiology   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^f ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; METABOLIC DISORDER; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SITTING; SMOKING; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADULT; AGED; C-REACTIVE PROTEIN; CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SMOKING;

EID: 33846785300     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.10.016     Document Type: Article

References (30)

1. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
2. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 106 (2002) 3143-3421
4. Razak F., Anand S., Vuksan V., Davis B., Jacobs R., Teo K.K., et al. SHARE Investigators. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes 29 (2005) 656-667
5. Mahley R.W., Palaoǧlu E., Atak Z., et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 36 (1995) 839-859
6. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 156 (2001) 1-10
7. Onat A., Ceyhan K., Başar Ö., Erer B., Toprak S., and Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002) 285-292
8. Onat A., Avci{dotless} G.Ş., Şenocak M., Örnek E., and Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J Epidemiol Community 46 (1992) 470-476
9. Genuth S., Alberti K.G., Bennett P., et al., Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
10. Onat A., Avci{dotless} G.Ş., Barlan M.M., Uyarel H., Uzunlar B., and Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes 28 (2004) 1018-1025
11. Onat A., Hergenç G., Uzunlar B., et al. Determinants of HDL-cholesterol and is prediction of coronary disease among Turks (summary in English). Arch Turk Soc Cardiol 31 (2003) 9-16
12. Wyszynski D.F., Waterworth D.M., Barter P.J., et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 95 (2005) 194-198
13. Rose G.A., Blackburn H., Gillum R.F., and Prineas R.J. Cardiovascular survey methods. 2nd ed. (1982), WHO, Geneva 124-127
14. Misra A., Vikram N.K., Gupta R., Pandey R.M., Wasir J.S., and Gupta V.P. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes 30 (2006) 106-111
15. McLaughlin T., Abbasi F., Lamendola C., Liang L., Reaven G., Schaaf P., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106 (2002) 2908-2912
16. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22 (1999) 1971-1977
17. Chambers J.C., Eda S., Bassett P., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104 (2001) 145-150
18. Erem C., Arslan C., Haci{dotless}hasanoglu A., et al. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res 12 (2004) 1117-1127
19. Filozof C., Fernandez M., Pinilla C., and Fernandez-Cruz A. Smoking cessation and weight gain. Obes Rev 5 (2004) 95-103
20. Onat A., Hergenç G., Türkmen S., Yazi{dotless}ci{dotless} M., Sari{dotless} i{dotless}., and Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 55 (2006) 445-452
21. Carnethon M.R., Fortmann S.P., Palaniappan L., Duncan B.B., Schmidt M.I., and Chambless L.E. Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 158 (2003) 1058-1067
22. Rönnemaa T., Rönnemaa E.M., Puukka P., Pyörala K., and Laakso M. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care 19 (1996) 1229-1232
23. Ishizaka N., Ishizaka Y., Toda E.-I., Nagai R., and Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 25 (2005) 1038-1044
24. Czernichow S., Bertrais S., Preziosi P., Galan P., Hercberg S., Oppert J.M., and SU.VI.MAX study. Indicators of abdominal adiposity in middle-aged participants of the SU.VI.MAX study: relationships with educational level, smoking status and physical inactivity. Diabetes Metab 30 (2004) 110-111
25. Han T.S., Van Lee E.M., Seidell J.C., and Lean M.E. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311 (1995) 1401-1405
26. Deurenberg-Yap M., Chew S.K., and Deurenberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese. Obes Rev 3 (2002) 209-215
27. Tuomilehto J., Lindström J., Eriksson J.G., et al., for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
28. Knowler W.C., Barrett-Connor E., Fowler S.E., et al., Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) v-403
29. Manson J.E., Rimm E.B., Stampfer M.J., et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338 (1991) 774-778
30. Bigaard J., Tjonneland A., Thomsen B.L., Overvad K., Heitmann B.L., and Sörensen T.I.A. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res 11 (2003) 895-903